Inactive Instrument

Evogene Ltd. Stock price TEL AVIV STOCK EXCHANGE

Equities

EVGN

IL0011050551

Biotechnology & Medical Research

Sales 2023 5.64M 20.76M Sales 2024 * 20.3M 74.72M Capitalization 37.23M 137M
Net income 2023 -23M -84.66M Net income 2024 * -20M -73.62M EV / Sales 2023 7.44 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 1.83 x
P/E ratio 2023 *
-
P/E ratio 2024 *
-
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 98.27%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 58 01-12-31
Director of Finance/CFO 57 22-03-31
Chief Tech/Sci/R&D Officer 48 04-12-31
Members of the board TitleAgeSince
Director/Board Member 79 21-11-16
Chairman 58 16-08-10
Director/Board Member 76 05-04-30
More insiders
Evogene Ltd is an Israel-based company, engaged in leveraging computational biology to design products for life-science-based industries including human health, agriculture, and industrial applications. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.
More about the company
  1. Stock
  2. Equities
  3. Stock Evogene Ltd.
  4. Stock Evogene Ltd. - TEL AVIV STOCK EXCHANGE